Praxis Precision Medicines, Inc. - Common Stock (PRAX)
CUSIP: 74006W207
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 25,726,377
- Total 13F shares
- 18,424,832
- Share change
- +2,500,379
- Total reported value
- $762,133,327
- Put/Call ratio
- 93%
- Price per share
- $41.36
- Number of holders
- 113
- Value change
- +$67,529,667
- Number of buys
- 79
- Number of sells
- 58
Quarterly Holders Quick Answers
What is CUSIP 74006W207?
CUSIP 74006W207 identifies PRAX - Praxis Precision Medicines, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74006W207:
Top shareholders of PRAX - Praxis Precision Medicines, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Clarus Lifesciences III, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,894,109
|
$123,282,606 | — | 12 May 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
5.4%
|
1,393,028
|
$85,002,569 | — | 31 Mar 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
5.1%
|
1,310,000
|
$79,936,200 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
3.7%
|
954,140
|
$58,221,623 | — | 31 Mar 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
3.2%
|
828,380
|
$50,547,748 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.2%
|
821,589
|
$50,133,361 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.9%
|
744,069
|
$45,403,090 | — | 31 Mar 2024 | |
| VR Adviser, LLC |
13F
|
Company |
2.7%
|
706,126
|
$43,087,809 | — | 31 Mar 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
2.1%
|
545,408
|
$33,280,796 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.1%
|
535,999
|
$32,707,000 | — | 31 Mar 2024 | |
| PFM Health Sciences, LP |
13F
|
Company |
1.9%
|
477,605
|
$29,143,457 | — | 31 Mar 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.8%
|
460,512
|
$28,100,442 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
1.7%
|
442,621
|
$27,008,733 | — | 31 Mar 2024 | |
| Velan Capital Investment Management LP |
13F
|
Company |
1.4%
|
350,666
|
$21,397,639 | — | 31 Mar 2024 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1.4%
|
350,000
|
$21,357,000 | — | 31 Mar 2024 | |
| 5AM Venture Management, LLC |
13F
|
Company |
1.3%
|
340,000
|
$20,746,800 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.2%
|
310,059
|
$18,877,950 | — | 31 Mar 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1%
|
266,496
|
$16,261,586 | — | 31 Mar 2024 | |
| Octagon Capital Advisors LP |
13F
|
Company |
1%
|
260,000
|
$15,865,200 | — | 31 Mar 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
0.87%
|
225,000
|
$13,729,500 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.86%
|
221,745
|
$13,530,880 | — | 31 Mar 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.82%
|
210,000
|
$12,814,200 | — | 31 Mar 2024 | |
| CIBC Asset Management Inc |
13F
|
Company |
0.75%
|
192,304
|
$11,734,390 | — | 31 Mar 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.74%
|
190,556
|
$11,627,727 | — | 31 Mar 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.69%
|
177,139
|
$10,809,022 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.69%
|
176,952
|
$10,797,611 | — | 31 Mar 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.65%
|
168,388
|
$10,275,036 | — | 31 Mar 2024 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.63%
|
162,302
|
$9,903,668 | — | 31 Mar 2024 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.62%
|
159,486
|
$9,731,836 | — | 31 Mar 2024 | |
| Logos Global Management LP |
13F
|
Company |
0.58%
|
150,000
|
$9,153,000 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.56%
|
145,295
|
$8,865,901 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.52%
|
134,717
|
$8,223,265 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.52%
|
132,942
|
$8,112,121 | — | 31 Mar 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.51%
|
131,533
|
$8,026,144 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.47%
|
121,024
|
$7,384,882 | — | 31 Mar 2024 | |
| Tri Locum Partners LP |
13F
|
Company |
0.41%
|
106,494
|
$6,498,264 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.41%
|
106,159
|
$6,477,822 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.39%
|
100,136
|
$6,110,298 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.38%
|
98,635
|
$6,018,708 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.37%
|
95,181
|
$5,807,945 | — | 31 Mar 2024 | |
| LMR Partners LLP |
13F
|
Company |
0.37%
|
94,332
|
$5,756,139 | — | 31 Mar 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.36%
|
93,000
|
$5,674,860 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.32%
|
82,254
|
$5,018,000 | — | 31 Mar 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
0.3%
|
78,100
|
$4,765,662 | — | 31 Mar 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.28%
|
71,253
|
$4,347,858 | — | 31 Mar 2024 | |
| 72 Investment Holdings, LLC |
13F
|
Company |
0.26%
|
65,933
|
$4,023,232 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.2%
|
51,548
|
$3,145,459 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.2%
|
51,372
|
$3,134,719 | — | 31 Mar 2024 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.19%
|
50,000
|
$3,051,000 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.18%
|
47,066
|
$2,871,967 | — | 31 Mar 2024 |
Institutional Holders of Praxis Precision Medicines, Inc. - Common Stock (PRAX) as of Q2 2024
As of 30 Jun 2024,
Praxis Precision Medicines, Inc. - Common Stock (PRAX) was held by
113 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,424,832 shares.
The largest 10 holders included
BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., Point72 Asset Management, L.P., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, PERCEPTIVE ADVISORS LLC, Verition Fund Management LLC, and VR Adviser, LLC.
This page lists
113
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
110
Q2 2024 holders
113
Holder diff
3
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.